Please login to the form below

Not currently logged in

Syndesi Therapeutics

This page shows the latest Syndesi Therapeutics news and features for those working in and with pharma, biotech and healthcare.

AbbVie acquires Syndesi Therapeutics in $1bn deal

AbbVie acquires Syndesi Therapeutics in $1bn deal

AbbVie has announced its acquisition of Syndesi Therapeutics, further expanding AbbVie’s neuroscience portfolio. ... The acquisition further reinforces AbbVie’s neurology pipeline, as four years ago, Syndesi Therapeutics gained the rights to UCB’s

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...